English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

A. FDA Efforts 168 B. Further Modifications in the Present System Designed to Improve the Accuracy of Experimental Data 170 1. Clinical Research Standards 170 2. Changes in Enforcement Policies 171 C. Alternatives to the Present System Designed to Improve the Accuracy of Experimental Data 175 1. Limited Third-Party Testing 175 2. Complete Third-Party Testing 177 (a) Government testing 177 (b) Independent contracting 179 VI. CONCLUSIONS AND RECOMMENDATIONS 181

Divorcing Profit Motivation from New Drug Research: A Consideration of Proposals to Provide the FDA with Reliable Test Data